Information

Dear user, the application need JavaScript support. Please enable JavaScript in your browser.

You are browsing as a GUEST
Title of the item:

Su1936 - Etrolizumab Treatment Leads to Early Improvement in Symptoms and Inflammatory Biomarkers in Anti-Tnfrefractory Patients in the Open-Label Induction Cohort of the Phase 3 Hickory Study.

Title :
Su1936 - Etrolizumab Treatment Leads to Early Improvement in Symptoms and Inflammatory Biomarkers in Anti-Tnfrefractory Patients in the Open-Label Induction Cohort of the Phase 3 Hickory Study.
Authors :
Peyrin-Biroulet, Laurent
Feagan, Brian G.
Mansfield, John
Rubin, David T.
Arulmani, Udayasankar
Maciuca, Romeo
Tyrrell, Helen
Thommes, James
Tole, Swati
Show more
Source :
Gastroenterology (00165085); Apr2017 Supplement 1, Vol. 152, pS603-S603, 1p
Academic Journal

We use cookies to help identify your computer so we can tailor your user experience, track shopping basket contents and remember where you are in the order process.